Our study corroborates these prior observations, demonstrating that both the 5:2 IF diet and daily calorie restriction can ameliorate liver steatosis and fibrosis, as well as decrease liver enzyme markers ALT and AST in patients with MAFLD-related metabolic fatty liver disease, even with a brief 12-week intervention period. The gene discussed is GPT; the disease is fatty liver disease.